Hemochromatosis, type 3 Clinical Trials

• Cardiac Function in Patients with Hereditary Hemochromatosis
  ClinicalTrials.gov Identifier: NCT00068159 - Active, not recruiting
  Hemochromatosis
  
• Erythrocyte Apheresis Versus Phlebotomy in Hemochromatosis
  ClinicalTrials.gov Identifier: NCT00509652 - Recruiting
  Hemochromatosis
  
• Deferoxamine for the Treatment of Hemochromatosis
  ClinicalTrials.gov Identifier: NCT00001203 - Active, not recruiting
  Diabetes Mellitus; Heart Disease; Hemochromatosis; Thalassemia
  
• Hemochromatosis and Iron Overload Screening Study (HEIRS)
  ClinicalTrials.gov Identifier: NCT00005541 - Active, not recruiting
  Blood Disease; Hemochromatosis; Iron Overload
  
• Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis
  ClinicalTrials.gov Identifier: NCT00395629 - Recruiting
  Hereditary Hemochromatosis
  
• Treatment of Hemochromatosis
  ClinicalTrials.gov Identifier: NCT00007150 - Recruiting
  Hemochromatosis
  
• Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
  ClinicalTrials.gov Identifier: NCT00350662 - Active, not recruiting
  Hemochromatosis
  
• Hemochromatosis--Genetic Prevalence and Penetrance
  ClinicalTrials.gov Identifier: NCT00006312 - Completed
  Blood Disease; Hemochromatosis
  
• Statistical Basis for Hemochromatosis Screening
  ClinicalTrials.gov Identifier: NCT00005559 - Completed
  Blood Disease; Hemochromatosis
  
• Post-Marketing Safety Study of GSK Biological''s Pediarix™ Vaccine.
  ClinicalTrials.gov Identifier: NCT00146835 - Active, not recruiting
  Prophylaxis: Diphtheria, tetanus, pertussis, hepatitis B, poliovirus type 1, type 2 and type 3
  
• Stroke with Transfusions Changing to Hydroxyurea (SWITCH)
  ClinicalTrials.gov Identifier: NCT00122980 - Recruiting
  Hemochromatosis; Cerebrovascular Accident; Anemia, Sickle Cell; Blood Disease
  
• Efficacy and Safety In Poorly Controlled Type 2 Diabetics
  ClinicalTrials.gov Identifier: NCT00044460 - Active, not recruiting
  type 2 diabetes
  
• An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00229658 - Active, not recruiting
  Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
  
• Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
  ClinicalTrials.gov Identifier: NCT00202436 - Recruiting
  Hemochromatosis
  
• Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
  ClinicalTrials.gov Identifier: NCT00440986 - Completed
  Hereditary Hemochromatosis
  
• Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00151762 - Active, not recruiting
  Type 2 Diabetes
  
• Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-Dependent Patients
  ClinicalTrials.gov Identifier: NCT00349453 - Recruiting
  Hemochromatosis
  
• Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression
  ClinicalTrials.gov Identifier: NCT00133809 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00308737 - Active, not recruiting
  Diabetes Mellitus, Type I; Diabetes Mellitus, Type II
  
• A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00521378 - Active, not recruiting
  Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
  
• Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
  ClinicalTrials.gov Identifier: NCT00032487 - Active, not recruiting
  Type 2 diabetes mellitus
  
• Effects of Vitamin B1 in Type 1 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00117026 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Study In People With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00196989 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Effect of Metformin in Patients with Type-1 Diabetes with Inadequate Glycaemic Control by Insulin and Diet
  ClinicalTrials.gov Identifier: NCT00118937 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Dietary Interventions in Type 2 Obese Diabetic Patients in the Community
  ClinicalTrials.gov Identifier: NCT00520182 - Active, not recruiting
  Diabetes Type 2
  
• Influence of Physical Training on Mitochondrial Function in Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00365495 - Active, not recruiting
  Type 2 Diabetes
  
• A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1
  ClinicalTrials.gov Identifier: NCT00239148 - Active, not recruiting
  Type 1 Diabetes
  
• A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1
  ClinicalTrials.gov Identifier: NCT00239187 - Active, not recruiting
  Type 2 Diabetes
  
• Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
  ClinicalTrials.gov Identifier: NCT00334503 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• 4 Weeks Treatment of Type II Diabetic Patients With BI 44847
  ClinicalTrials.gov Identifier: NCT00558909 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Surgical Treatment of Non-Obese Type 2 Diabetic Patients With Duodenal Exclusion
  ClinicalTrials.gov Identifier: NCT00566358 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
  ClinicalTrials.gov Identifier: NCT00334399 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients
  ClinicalTrials.gov Identifier: NCT00260234 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
  ClinicalTrials.gov Identifier: NCT00566813 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Family Management of Type 1 Diabetes in Children
  ClinicalTrials.gov Identifier: NCT00273286 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients with Type 2 Diabetes.
  ClinicalTrials.gov Identifier: NCT00145925 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• A 2 Year Random Control Trial of Patients with Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control
  ClinicalTrials.gov Identifier: NCT00133718 - Active, not recruiting
  Diabetes Mellitus; Type 2 Diabetes Mellitus
  
• Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes
  ClinicalTrials.gov Identifier: NCT00118963 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Efficacy and Safety of Vildagliptin in Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00102388 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Efficacy and Safety of Vildagliptin in Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00106340 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
  ClinicalTrials.gov Identifier: NCT00100178 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Long-term Study of Starlix+Diovan to Delay Type II Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00097786 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Insulin NovoRapid Vs. Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose
  ClinicalTrials.gov Identifier: NCT00145353 - Active, not recruiting
  Type 1 diabetes mellitus
  
• A Randomized, Controlled Study on Ca Blocker Vs. AII Antagonists in Hypertension with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00144144 - Active, not recruiting
  Hypertension; Diabetes Mellitus, Type 2
  
• Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
  ClinicalTrials.gov Identifier: NCT00000595 - Completed
  Anemia (Iron-Loading); beta-Thalassemia; Hematologic Diseases; Hemoglobinopathies; Thalassemia; Iron Overload; Hemochromatosis
  
• The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00279201 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00447382 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00490867 - Active, not recruiting
  Type 2 Diabetes
  
• Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care
  ClinicalTrials.gov Identifier: NCT00194558 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00200018 - Active, not recruiting
  Severe to Morbid Obesity and Type 2 Diabetes
  
• Placebo-Controlled Study of the Combination of SYR-322 and Pioglitazone HCl in the Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00328627 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00351884 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00395746 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Natural History Study of Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1
  ClinicalTrials.gov Identifier: NCT00445991 - Active, not recruiting
  Neurofibromatosis Type 1 (nf1); Precancerous/Nonmalignant Condition
  
• Safety and Efficacy of Inhaled Pre-Prandial Human Insulin in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00343980 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Randomized Study of Real-Time Continuous Glucose Monitors in the Management of Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00406133 - Active, not recruiting
  Type 1 Diabetes
  
• Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00202033 - Active, not recruiting
  Type 2 Diabetes
  
• A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
  ClinicalTrials.gov Identifier: NCT00374907 - Active, not recruiting
  Type 2 Diabetes
  
• Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00376038 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00389415 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
  ClinicalTrials.gov Identifier: NCT00460941 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Effect of Real Time Continuous Glucose Monitoring System on the Management of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00536549 - Active, not recruiting
  Type 2 Diabetes
  
• Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
  ClinicalTrials.gov Identifier: NCT00564018 - Enrolling by invitation
  Type 1 Diabetes
  
• Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin
  ClinicalTrials.gov Identifier: NCT00396071 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00518882 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00330473 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk
  ClinicalTrials.gov Identifier: NCT00179777 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00237237 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Study of SYR-322 Combined With Metformin in the Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00286442 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of SYR-322 Combined With a Sulfonylurea in the Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00286468 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of SYR-322 Combined With Pioglitazone in the Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00286494 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00325364 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Long-Term Safety Study of Vildagliptin in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00325429 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00393718 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• GOAL Life-Style Change Intervention to Prevent Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00398060 - Active, not recruiting
  Obesity; Type 2 Diabetes
  
• Vildagliptin 100 mg Once Daily vs. Placebo as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
  ClinicalTrials.gov Identifier: NCT00494884 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00191282 - Active, not recruiting
  Type 2 Diabetes; Acute Myocardial Infarction
  
• Non-Traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00256607 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Markers and Mechanisms of Vascular Disease in Type II Diabetes
  ClinicalTrials.gov Identifier: NCT00256646 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Effects of Rituximab on the Progression of Type 1 Diabetes in New Onset Subjects
  ClinicalTrials.gov Identifier: NCT00279305 - Active, not recruiting
  Type 1 Diabetes Mellitus
  
• Study of SYR-322 Combined With Insulin in the Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00286429 - Active, not recruiting
  Type 2 Diabetes
  
• Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00308308 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Efficacy and Safety of 3 Doses of BI1356 in Type 2 Diabetes Patients
  ClinicalTrials.gov Identifier: NCT00328172 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy
  ClinicalTrials.gov Identifier: NCT00328302 - Active, not recruiting
  Diabetes, Type I
  
• Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00377676 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Efficacy and Safety of Vildagliptin vs. Placebo in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00390520 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Middle-School Based Primary Prevention Trial of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00458029 - Active, not recruiting
  Type 2 Diabetes
  
• Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine
  ClinicalTrials.gov Identifier: NCT00518427 - Active, not recruiting
  Diabetes Type 2
  
• School Centered Telemedicine Program for Children With Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00566475 - Active, not recruiting
  Type 1 Diabetes
  
• Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
  ClinicalTrials.gov Identifier: NCT00199628 - Recruiting
  Glomerulonephritis, Membranous; Neonatal Diseases and Abnormalities; Hemochromatosis
  
• ASCEND: A Study of Cardiovascular Events iN Diabetes
  ClinicalTrials.gov Identifier: NCT00135226 - Recruiting
  Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
  
• Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients
  ClinicalTrials.gov Identifier: NCT00473655 - Recruiting
  Hypertriglyceridemia; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemia Type IIb; Hyperlipidemia
  
• Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00356109 - Active, not recruiting
  Type 1 Diabetes Mellitus
  
• A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00357370 - Active, not recruiting
  Type 2 Diabetes
  
• Exenatide Versus Glimepiride in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00359762 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of SYR-322 in the Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00286455 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria
  ClinicalTrials.gov Identifier: NCT00320008 - Active, not recruiting
  Type 2 Diabetes
  
• Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00322257 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00331604 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00435981 - Active, not recruiting
  Type 1 Diabetes